Regarding the transcription factors' binding sites on THOR, while the MZF‐2 binding sites were hypermethylated in all tumor samples and the E‐box site was hypomethylated in almost all tumor samples (87%, 13/15 cell lines and patients); WT1 binding site presented different methylation levels between tumor samples (cell lines and patients). The gene discussed is WT1; the disease is neoplasm.